Class denied for brand loyalty
A federal judge on Tuesday said that lawyers representing the buyers of two cancer drugs must sort out which buyers would not have switched to a generic version of the medication because of brand loyalty before she would grant those plaintiffs class certification.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10